The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...

Bain Capital is making a play for full control of Surgery Partners ... Surgery Partners' strong financials$770 million in ...

On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...

CEO Hess discussed the company's divestiture of TRANZACT for $632 million, expected to enhance growth, operating margins, and free cash flow starting in 2025. The reentry into the reinsurance market ...

Bain Capital Specialty Finance (NYSE:BCSF – Get Free Report) had its price target lifted by analysts at Wells Fargo & Company from $17.00 to $18.00 in a research note issued to investors on Wednesday, ...

Sources said Bain Capital, which was among the parties weighing a first-round bid, had baulked at K1’s sky-high price ...

Apollo Global Management shares fell after KKR's rival posted a drop in quarterly revenue. Apollo Chief Executive Marc Rowan said its of Argo Infrastructure Partners, a fund manager with about $6 ...

Surgery Partners has received an acquisition offer the could take the public company private. Boston-based Bain Capital Partners has made an offer to purchase all outstanding shares of the company for ...